Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8072

7 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A dot plot chart showing pharmacokinetic fold changes and 90% confidence intervals for venlafaxine when co-administered with various interacting drugs. The vertical axis lists interacting drugs and analytes, while the horizontal axis measures fold changes relative to a reference value from 0 to 3. Recommendations for dose adjustment or caution accompany each interacting drug.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A chart showing pharmacokinetic (PK) fold changes and 90% confidence intervals for various interacting drugs with their analytes, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents change relative to a reference value, accompanied by dosing recommendations such as dose adjustment advice or clinical significance notes.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A dot plot chart depicting pharmacokinetic fold changes and 90% confidence intervals of venlafaxine and its ODV metabolite across special populations, including various degrees of hepatic and renal impairment, CYP2D6 polymorphism, age, and gender. The chart shows relative changes in concentration (Cmax, AUC) with associated dosing recommendations for adjustments where applicable.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxine HCl Extended-release Capsules Usp 150mg (Venlafaxine Hydrochloride 150mg 30 Capsules)

Venlafaxine HCl Extended-release Capsules Usp 150mg (Venlafaxine Hydrochloride 150mg 30 Capsules)
Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg packaging label. The label shows the generic name Venlafaxine Hydrochloride and strength 150 mg for extended-release oral capsules. The product is generic for Effexor ER. Manufacturer is noted as Camber Pharmaceuticals, Inc., Piscataway, NJ. The label includes storage instructions and a warning about controlled room temperature and child safety. Directions for use in English and Spanish are printed on a yellow background stating to take the capsules every specified number of hours.*
FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Venlafaxinestructure (Venlafaxinestructure)
Chemical structure of Venlafaxine Hydrochloride showing its molecular arrangement, including a chiral center, as depicted in the structural diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.